Lockheed Martin Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,500
| Closed | -$279K | – | 133 |
|
|
2018
Q1 | $279K | Buy |
2,500
+500
| +25% | +$55.8K | 0.01% | 122 |
|
|
2017
Q4 | $239K | Sell |
2,000
-6,000
| -75% | -$717K | 0.01% | 124 |
|
|
2017
Q3 | $1.12M | Sell |
8,000
-9,200
| -53% | -$1.29M | 0.06% | 99 |
|
|
2017
Q2 | $2.09M | Buy |
17,200
+7,000
| +69% | +$852K | 0.11% | 85 |
|
|
2017
Q1 | $1.24M | Sell |
10,200
-10,000
| -50% | -$1.21M | 0.07% | 104 |
|
|
2016
Q4 | $2.47M | Sell |
20,200
-9,400
| -32% | -$1.15M | 0.21% | 57 |
|
|
2016
Q3 | $3.63M | Buy |
29,600
+9,600
| +48% | +$1.18M | 0.31% | 46 |
|
|
2016
Q2 | $2.34M | Buy |
+20,000
| New | +$2.34M | 0.23% | 63 |
|
|
2015
Q4 | – | Sell |
-6,500
| Closed | -$1.02M | – | 106 |
|
|
2015
Q3 | $1.02M | Sell |
6,500
-19,000
| -75% | -$2.97M | 0.11% | 65 |
|
|
2015
Q2 | $4.61M | Sell |
25,500
-9,200
| -27% | -$1.66M | 0.23% | 49 |
|
|
2015
Q1 | $6.01M | Buy |
34,700
+20,700
| +148% | +$3.59M | 0.29% | 41 |
|
|
2014
Q4 | $2.59M | Sell |
14,000
-2,000
| -13% | -$370K | 0.11% | 56 |
|
|
2014
Q3 | $2.65M | Buy |
+16,000
| New | +$2.65M | 0.12% | 63 |
|